These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8605099)

  • 1. Allelic imbalance in the region of the BRCA1 gene in ductal carcinoma in situ of the breast.
    Munn KE; Walker RA; Menasce L; Varley JM
    Br J Cancer; 1996 Mar; 73(5):636-9. PubMed ID: 8605099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation of the TP53 gene and allelic imbalance at chromosome 17p13 in ductal carcinoma in situ.
    Munn KE; Walker RA; Menasce L; Varley JM
    Br J Cancer; 1996 Nov; 74(10):1578-85. PubMed ID: 8932338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four regions of allelic imbalance on 17q12-qter associated with high-grade breast tumors.
    Plummer SJ; Paris MJ; Myles J; Tubbs R; Crowe J; Casey G
    Genes Chromosomes Cancer; 1997 Dec; 20(4):354-62. PubMed ID: 9408751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic loss of the BRCA1 and BRCA2 genes and other regions on 17q and 13q in breast cancer among women from Taiwan (area of low incidence but early onset).
    Lo YL; Yu JC; Huang CS; Tseng SL; Chang TM; Chang KJ; Wu CW; Shen CY
    Int J Cancer; 1998 Dec; 79(6):580-7. PubMed ID: 9842965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification units and translocation at chromosome 17q and c-erbB-2 overexpression in the pathogenesis of breast cancer.
    Coene ED; Schelfhout V; Winkler RA; Schelfhout AM; Van Roy N; Grooteclaes M; Speleman F; De Potter CR
    Virchows Arch; 1997 May; 430(5):365-72. PubMed ID: 9174626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic imbalance and microsatellite instability in BRCA1 associated breast and ovarian tumors.
    van der Looij M; Papp J; Sztán M; Pulay T; Elfadil I; Besznyak I; Tóth J; Devilee P; Oláh E
    Int J Oncol; 2001 Apr; 18(4):775-80. PubMed ID: 11251173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High frequency of allelic imbalance at the BRCA1 region on chromosome 17q in both familial and sporadic ductal breast carcinomas.
    Borg A; Zhang QX; Johannsson O; Olsson H
    J Natl Cancer Inst; 1994 May; 86(10):792-4. PubMed ID: 8169978
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined loss of BRCA1/BRCA2 in grade 3 breast carcinomas.
    Kelsell DP; Spurr NK; Barnes DM; Gusterson B; Bishop DT
    Lancet; 1996 Jun; 347(9014):1554-5. PubMed ID: 8684125
    [No Abstract]   [Full Text] [Related]  

  • 9. Frequent alterations of chromosome 1 in ductal carcinoma in situ of the breast.
    Munn KE; Walker RA; Varley JM
    Oncogene; 1995 Apr; 10(8):1653-7. PubMed ID: 7731721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium.
    Lancet; 1997 May; 349(9064):1505-10. PubMed ID: 9167459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast.
    Fujii H; Szumel R; Marsh C; Zhou W; Gabrielson E
    Cancer Res; 1996 Nov; 56(22):5260-5. PubMed ID: 8912866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q.
    Radford DM; Fair KL; Phillips NJ; Ritter JH; Steinbrueck T; Holt MS; Donis-Keller H
    Cancer Res; 1995 Aug; 55(15):3399-405. PubMed ID: 7614479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer.
    Beckmann MW; Picard F; An HX; van Roeyen CR; Dominik SI; Mosny DS; Schnürch HG; Bender HG; Niederacher D
    Br J Cancer; 1996 May; 73(10):1220-6. PubMed ID: 8630282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis.
    Murphy DS; Hoare SF; Going JJ; Mallon EE; George WD; Kaye SB; Brown R; Black DM; Keith WN
    J Natl Cancer Inst; 1995 Nov; 87(22):1694-704. PubMed ID: 7473818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA-associated breast cancer: absence of a characteristic immunophenotype.
    Robson M; Rajan P; Rosen PP; Gilewski T; Hirschaut Y; Pressman P; Haas B; Norton L; Offit K
    Cancer Res; 1998 May; 58(9):1839-42. PubMed ID: 9581822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity at chromosome 9p in ductal carcinoma in situ and invasive carcinoma of the breast.
    Marsh KL; Varley JM
    Br J Cancer; 1998 May; 77(9):1439-47. PubMed ID: 9652759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between loss of heterozygosity of BRCA1 and BRCA2 and morphological attributes of sporadic breast cancer.
    Hanby AM; Kelsell DP; Potts HW; Gillett CE; Bishop DT; Spurr NK; Barnes DM
    Int J Cancer; 2000 Oct; 88(2):204-8. PubMed ID: 11004669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal alterations associated with the transition from in situ to invasive breast cancer.
    Ellsworth RE; Vertrees A; Love B; Hooke JA; Ellsworth DL; Shriver CD
    Ann Surg Oncol; 2008 Sep; 15(9):2519-25. PubMed ID: 18622645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histoprognostic grade in tumours from families with hereditary predisposition to breast cancer.
    Bignon YJ; Fonck Y; Chassagne MC
    Lancet; 1995 Jul; 346(8969):258. PubMed ID: 7616837
    [No Abstract]   [Full Text] [Related]  

  • 20. Allelic loss of chromosomal arm 8p in breast cancer progression.
    Anbazhagan R; Fujii H; Gabrielson E
    Am J Pathol; 1998 Mar; 152(3):815-9. PubMed ID: 9502423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.